AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. LGVN
  4. [Form 4] Longeveron Inc. Insider Trading Activity

[Form 4] Longeveron Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Filing content is currently unavailable.

Source:

Stock LGVN logo
Longeveron Inc

NASDAQ:LGVN

LGVN Rankings

#8747 Ranked by Market Cap
N/A Ranked by Dividends

LGVN Latest News

Aug 8, 2025
Longeveron Announces Up To $17.5 Million Public Offering
Aug 5, 2025
Longeveron庐 to Report Second Quarter 2025 Financial Results and Host Conference Call on August 13, 2025
Jul 21, 2025
Longeveron庐 Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease
Jul 8, 2025
Longeveron庐 Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)
Jun 26, 2025
Longeveron庐 Appoints Than Powell as Chief Business Officer

LGVN Latest SEC Filings

Aug 8, 2025
[S-1/A] Longeveron Inc. Amends IPO Registration Statement
Aug 4, 2025
[S-1] Longeveron Inc. Files IPO Registration Statement
Jul 17, 2025
[Form 4] Longeveron Inc. Insider Trading Activity
Jul 17, 2025
[Form 4] Longeveron Inc. Insider Trading Activity
Jul 17, 2025
[Form 4] Longeveron Inc. Insider Trading Activity

LGVN Stock Data

22.44M
11.86M
12.3%
8.59%
3.97%
Biotechnology
Pharmaceutical Preparations
United States
MIAMI